SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001437749-25-037874 from GeoVax Labs, Inc. (GOVX)

GeoVax Labs, Inc.
Date: Dec. 15, 2025 · CIK: 0000832489 · Accession: 0001437749-25-037874

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-292127

Date
December 15, 2025
Author
President
Form
CORRESP
Company
GeoVax Labs, Inc.

Letter

govx20251215_corresp.htm

Roth Capital Partners, LLC

888 San Clemente Drive, Suite 400

Newport Beach, CA 92660

December 15, 2025

VIA EDGAR CORRESPONDENCE

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E. Washington, D.C. 20549

Re:

GeoVax Labs, Inc. Registration Statement on Form S-1

File No. 333-292127

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), we, the placement agent, hereby request that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced registration statement on Form S-1 (the “Registration Statement”) to become effective at 5:00 p.m., Eastern Time, on Wednesday, December 17, 2025 or as soon thereafter as practicable.

Pursuant to Rule 460 under the Act, we wish to advise you that we have distributed as many copies of the Preliminary Prospectus dated December 12, 2025, to agents, dealers, institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The undersigned, as placement agent, has complied and will comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

If you require any additional information with respect to this letter, please contact Ali Panjwani at (212) 326-0820 of Pryor Cashman LLP.

Very truly yours,
ROTH CAPITAL PARTNERS, LLC

Show Raw Text
CORRESP
 1
 filename1.htm

 govx20251215_corresp.htm

 Roth Capital Partners, LLC

 888 San Clemente Drive, Suite 400

 Newport Beach, CA 92660

 December 15, 2025

 VIA EDGAR CORRESPONDENCE

 U.S. Securities and Exchange Commission

 Division of Corporation Finance

 100 F Street, N.E.
 Washington, D.C. 20549

 Re:

 GeoVax Labs, Inc.
 Registration Statement on Form S-1

 File No. 333-292127

 Ladies and Gentlemen:

 Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), we, the placement agent, hereby request that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced registration statement on Form S-1 (the “Registration Statement”) to become effective at 5:00 p.m., Eastern Time, on Wednesday, December 17, 2025 or as soon thereafter as practicable.

 Pursuant to Rule 460 under the Act, we wish to advise you that we have distributed as many copies of the Preliminary Prospectus dated December 12, 2025, to agents, dealers, institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

 The undersigned, as placement agent, has complied and will comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 If you require any additional information with respect to this letter, please contact Ali Panjwani at (212) 326-0820 of Pryor Cashman LLP.

 Very truly yours,

 ROTH CAPITAL PARTNERS, LLC

 By:

 /s/ Aaron M. Gurewitz

 Aaron M. Gurewitz

 President

 cc:

 M. Ali Panjwani, Esq.

 Pryor Cashman LLP